Spectrum Pharmaceuticals Inc. [NASDAQ: SPPI] traded at a high on 08/20/20, posting a 4.92 gain after which it closed the day’ session at $4.05. The company report on August 10, 2020 that Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update.
Recently announced positive topline results in HER2 exon 20 insertion mutations from Cohort 2 of the poziotinib ZENITH20 trial.
Company is in process of requesting a pre-NDA meeting with the FDA seeking an indication for second-line NSCLC patients with HER2 exon 20 insertion mutations.
The results of the trading session contributed to over 1867057 shares changing hands. Over the past one week, the price volatility of Spectrum Pharmaceuticals Inc. stands at 3.69% while the volatility over the past one month is 7.71%.
The market cap for SPPI stock reached $596.57 million, with 145.73 million shares outstanding and 133.76 million shares in the current float. Compared to the average trading volume of 2.33M shares, SPPI reached a trading volume of 1867057 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Spectrum Pharmaceuticals Inc. [SPPI]?
Guggenheim have made an estimate for Spectrum Pharmaceuticals Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 26, 2019. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price from $17 to $4. The new note on the price target was released on December 26, 2019, representing the official price target for Spectrum Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $18, while B. Riley FBR analysts kept a Buy rating on SPPI stock.
The Average True Range (ATR) for Spectrum Pharmaceuticals Inc. is set at 0.25 The Price to Book ratio for the last quarter was 3.49, with the Price to Cash per share for the same quarter was set at 1.06.
How has SPPI stock performed recently?
Spectrum Pharmaceuticals Inc. [SPPI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.14. With this latest performance, SPPI shares gained by 21.62% in over the last four-week period, additionally plugging by 33.22% over the last 6 months – not to mention a drop of -51.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SPPI stock in for the last two-week period is set at 62.39, with the RSI for the last a single of trading hit 67.35, and the three-weeks RSI is set at 60.56 for Spectrum Pharmaceuticals Inc. [SPPI]. The present Moving Average for the last 50 days of trading for this stock 3.39, while it was recorded at 3.84 for the last single week of trading, and 4.01 for the last 200 days.
Spectrum Pharmaceuticals Inc. [SPPI]: Deeper insight into the fundamentals
Return on Total Capital for SPPI is now -58.19, given the latest momentum, and Return on Invested Capital for the company is -56.88. Return on Equity for this stock declined to -57.17, with Return on Assets sitting at -41.20. When it comes to the capital structure of this company, Spectrum Pharmaceuticals Inc. [SPPI] has a Total Debt to Total Equity ratio set at 2.13. Additionally, SPPI Total Debt to Total Capital is recorded at 2.09, with Total Debt to Total Assets ending up at 1.54. Long-Term Debt to Equity for the company is recorded at 1.25, with the Long-Term Debt to Total Capital now at 1.22.
Reflecting on the efficiency of the workforce at the company, Spectrum Pharmaceuticals Inc. [SPPI] managed to generate an average of -$927,301 per employee.Spectrum Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Current Ratio set at 3.20.
Earnings analysis for Spectrum Pharmaceuticals Inc. [SPPI]
With the latest financial reports released by the company, Spectrum Pharmaceuticals Inc. posted -0.23/share EPS, while the average EPS was predicted by analysts to be reported at -0.41/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 43.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SPPI.
Insider trade positions for Spectrum Pharmaceuticals Inc. [SPPI]
There are presently around $304 million, or 50.30% of SPPI stock, in the hands of institutional investors. The top three institutional holders of SPPI stocks are: BLACKROCK INC. with ownership of 19,389,487, which is approximately 6.027% of the company’s market cap and around 1.60% of the total institutional ownership; VANGUARD GROUP INC, holding 12,121,314 shares of the stock with an approximate value of $49.09 million in SPPI stocks shares; and STATE STREET CORP, currently with $27.48 million in SPPI stock with ownership of nearly 29.19% of the company’s market capitalization.
87 institutional holders increased their position in Spectrum Pharmaceuticals Inc. [NASDAQ:SPPI] by around 8,182,299 shares. Additionally, 53 investors decreased positions by around 6,360,630 shares, while 39 investors held positions by with 60,490,235 shares. The mentioned changes placed institutional holdings at 75,033,164 shares, according to the latest SEC report filing. SPPI stock had 21 new institutional investments in for a total of 441,641 shares, while 18 institutional investors sold positions of 1,568,402 shares during the same period.